PEARL-II: Oral ‘3D’ regimen effective in hepatitis C with prior treatment failure

CHICAGO – The investigational "3D" combination of oral antiviral drugs achieved a cure rate that was nothing short of sensational in the phase III PEARL-II trial involving noncirrhotic...